Company Filing History:
Years Active: 2020
Title: The Innovative Contributions of Saad Z Usmani
Introduction
Saad Z Usmani is a prominent inventor based in Charlotte, NC (US). He has made significant contributions to the field of medical research, particularly in the area of plasma cell disorders and multiple myeloma. With a total of 2 patents, his work has the potential to impact patient care and treatment outcomes.
Latest Patents
Usmani's latest patents include innovative methods aimed at improving the understanding and treatment of plasma cell disorders. The first patent, titled "Methods of determining IMiDS resistance in plasma cell disorders," provides techniques for assessing immunomodulatory derivatives (IMiDs) resistance in patients suffering from these conditions. The second patent, "Immune profiling and minimal residue disease following stem cell transplantation in multiple myeloma," outlines methods for evaluating minimal residue disease (MRD) in multiple myeloma patients. This invention involves analyzing the distribution and activation of peripheral natural killer (NK), NK-T, and T cells, as well as quantifying inflammatory cytokines, chemokines, and growth factors in biological samples. The results can help determine the MRD status in patients, which is crucial for effective treatment planning.
Career Highlights
Saad Z Usmani is affiliated with the Charlotte-Mecklenburg Hospital Authority, where he applies his expertise in medical research and innovation. His work is instrumental in advancing the understanding of complex medical conditions and improving therapeutic strategies.
Collaborations
Usmani collaborates with esteemed colleagues, including Qing Zhang and Manisha Bhutani, to further enhance research outcomes and drive innovation in the medical field.
Conclusion
Saad Z Usmani's contributions to medical research through his patents and collaborations highlight his commitment to improving patient care in plasma cell disorders and multiple myeloma. His innovative approaches are paving the way for advancements in treatment and patient management.